A Study of Real-world Outcomes Among Patients Treated With Ribociclib

Clinical trial NCT07148505 · COMPLETED

Trial details

NCT number: NCT07148505
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Breast Cancer

Start date: 2024-04-24
Primary completion: 2024-11-07
Enrollment: 373

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.